GSE114403 Immune profiling of pre- and post-treatment breast cancer tissues from the SOWG S0800 randomized neoadjuvant trail of weekly nab-paclitaxel with or without bevacizumab and dose dense doxorubicin and cyclophosphamide
Conclusions: High mast cell gene expression is associated with lower pCR rate. TIL counts and most immune parameters decrease after neoadjuvant chemotherapy.
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Homo sapiens Source Type: research
More News: Avastin | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Gastroschisis Repair | Genetics | Nanotechnology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy